ProMIS Neurosciences Inc.
PMN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374339
In the last 90 days, ProMIS Neurosciences Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $84.3M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding ProMIS Neurosciences Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 3 | 2 | −1 |
| Shares | 98.5K | 83.5K | −15.0K (−15.2%) |
| Value | $14.0K | $9.00K | −$5.00K (−35.7%) |
New holders (0)
Institutions that held ProMIS Neurosciences Inc. at the end of Q4 2021 but not at the end of Q3 2021.
None.
Sold out (1)
Institutions that held ProMIS Neurosciences Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Livingston Group Asset Management CO (operating as Southport Capital Management) | 15,000 | $2.00K |